- Report
- May 2024
- 133 Pages
Global
From €6122EUR$6,499USD£5,235GBP
- Report
- January 2022
- 60 Pages
Global
From €3721EUR$3,950USD£3,182GBP
- Report
- January 2022
- 200 Pages
Global
From €7065EUR$7,500USD£6,041GBP
Tendinopathy is a medical condition that affects the tendons, which are the fibrous tissues that connect muscles to bones. It is a common condition that can cause pain, swelling, and stiffness in the affected area. It can be caused by overuse, injury, or age-related degeneration. Treatment options for tendinopathy include rest, physical therapy, medications, and in some cases, surgery.
The tendinopathy market is a growing segment of the therapeutic area, with a focus on providing treatments that reduce pain and improve mobility. Companies in this market are developing innovative therapies to address the needs of patients with tendinopathy. These include biologics, regenerative medicine, and other treatments.
Some companies in the tendinopathy market include Allergan, AstraZeneca, Biogen, Eli Lilly, and Regeneron. Show Less Read more